In the literature, several terms are used synonymously to name the topic of this book: chem-, chemi-, or chemo-informatics. A widely recognized de- nition of this discipline is the one by Frank Brown from 1998 (1) who defined chemoinformatics as the combination of "all the information resources that a scientist needs to optimize the properties of a ligand to become a drug. " In Brown's definition, two aspects play a fundamentally important role: de- sion support by computational means and drug discovery, which distinguishes it from the term "chemical informatics" that was introduced at least ten years earlier and described as the application of information technology to ch- istry (not with a specific focus on drug discovery). In addition, there is of course "chemometrics," which is generally understood as the application of statistical methods to chemical data and the derivation of relevant statistical models and descriptors (2). The pharmaceutical focus of many developments and efforts in this area-and the current popularity of gene-to-drug or si- lar paradigms-is further reflected by the recent introduction of such terms as "discovery informatics" (3), which takes into account that gaining kno- edge from chemical data alone is not sufficient to be ultimately successful in drug discovery. Such insights are well in accord with other views that the boundaries between bio- and chemoinformatics are fluid and that these d- ciplines should be closely combined or merged to significantly impact b- technology or pharmaceutical research (4).

A collection of powerful new techniques for oligonucleotide synthesis and for the use of modified oligonucleotides in biotechnology. Among the protocol highlights are a novel two-step process that yields a high purity, less costly, DNA, the synthesis of phosphorothioates using new sulfur transfer agents, the synthesis of LNA, peptide conjugation methods to improve cellular delivery and cell-specific targeting, and triple helix formation. The applications include using molecular beacons to monitor the PCR amplification process, nuclease footprinting to study the sequence-selective binding of small molecules of DNA, nucleic acid libraries, and the use of small interference RNA (siRNA) as an inhibitor of gene expression.

"Drug Metabolism and Pharmacokinetics Quick Guide" covers a number of aspects of drug assessment at drug discovery and development stages, topics such as pharmacokinetics, absorption, metabolism, enzyme kinetics, drug transporters, drug interactions, drug-like properties, assays and in silico calculations. It covers key concepts, with useful tables on physiological parameters (eg. blood flow to organs in x-species, expression and localization of enzymes and transporters), chemical structure, nomenclature, and moieties leading to bioactivation (with examples). Overall it includes a number of key topics useful at the drug discovery stage, which would serve as a quick reference with several examples from the literature to illustrate the concept.

A comprehensive collection of readily reproducible methods for studying receptors in silico, in vitro, and in vivo. These cutting-edge techniques cover mining from curated databases, identifying novel receptors by high throughput screening, molecular methods to identify mRNA encoding receptors, radioligand binding assays and their analysis, quantitative autoradiography, and imaging receptors by positron emission tomography (PET). Highlights include phenotypic characterization of receptors in knockout mice, imaging receptors using green fluorescent protein and fluorescent resonance energy transfer, and quantitative analysis of receptor mRNA by TaqMan PCR. These book equips the researcher with techniques for exploring the unprecedented number of new receptor systems now emerging and the so-called "orphan" receptors whose activating ligand has not been identified.

A collection of readily reproducible bioinformatic methods to advance the drug discovery process from gene identification to protein modeling to the identification of specific drug candidates. The authors demonstrate these techniques, including microarray analysis, the analysis of genes as potential drug targets, virtual screening and in silico protein design, and cheminformatics, in a variety of practical situations. Because these technologies are still emergent, each chapter contains an extended introduction that explains the theory and application of the technology and techniques described.

Resorcinol chemistry has been providing valuable properties and products in the development of advanced technologies in the areas of pharmaceuticals, rubber compounds, wood composites and plastics. Notable technologies include steel belted radial tires, resorcinol-formaldehyde-latex adhesives (RFL), a weather proof polycarbonate (Sollx), a super heat resistant polymer (PEN-RTM), the world's strongest fiber (Zylon), sun screens (UV absorbers), Intal (an asthma drug), Ostivone (an osteoporosis drug), Throat Plus (lozenges), Centron and Saheli (oral contraceptive pills), and many more. This new resorcinol book contains information on the chemistry and technologies developed for the usefulness of human needs. Scientists and researchers around the world working in the areas of pharmaceuticals, rubber compounds (tires, hoses, belts), polymers, polymer additives (UV absorbers, flame retardants), composites (polymers and wood), photoresists, or just simply organic chemistry will benefit from this key resorcinol reference.

Protein and peptide therapeutics currently represent eight of the top 100 prescription pharmaceuticals in the U.S., and biotechnology products are projected to account for 15% of the total US. prescription drug market by 2003. Of the protein and peptide products now on the market, many are administered as daily injections, though several are deliveredby noninvasive routes. For example, desmopressin is delivered as a nasal spray, and deoxyribonuclease I is administered by inhalation. Although cyclosporin A is orally active, as yet there are no general means to confer oral bioava- ability to peptides and proteins. A major advance in delivery ofpeptides was achieved with the introduction of a monthly injectable, biodegradable microsphere formulation of LHRH. Despite the enormous success of biotechnology products to date, much effort continues to be focused on the development of more convenient and noninvasive routes of administration for those products that require f- quent and prolonged dosing. Here we present an overview of the te- nologies, both developed and emerging, which are applicable to protein delivery. In addition, chapters 11 through 13 detail case studies on physical methods for delivery ofinsulin and growth hormone

The endothelins are a remarkable family of signaling peptides: molecular biology predicted the existence of their receptors and synthetic enzymes prior to both the identification of the encoded proteins and the synthesis of antagonists and inhibitors for use as pharmacological tools. Although considerable advances have been made, culminating in the design of endothelin antagonists with the- peutic potential in cardiovascular disease, much remains to be discovered. Tantalizingly, new research frontiers are emerging. To support further progress, Peptide Research Protocols: Endothelin encompasses experimental protocols that interrogate all facets of an endogenous mammalian peptide s- tem, from peptide and receptor expression through synthetic pathway to peptide function and potential role in human disease. Chapters describe the use of molecular techniques to quantify the expression of mRNA for both endothelin receptors and the endothelin-converting enzymes. Peptides, precursors, receptors, and synthetic enzymes may be localized and quantified in plasma, culture supernatants, tissue homogenates, and tissue s- tions using antibodies, while additional information on receptor characterization may be obtained using radioligand binding techniques. Several protocols cover in vitro assays that determine the function of the endothelin peptides in isolated preparations, that characterize new endothelin receptor ligands, or provide inf- mation on the tissue-specific processing of endothelin precursor peptides.

Recent analyses of drug attrition rates reveal that a significant number of drug candidates fail in the later stage of clinical development owing to absorption, distribution, metabolism, elimination (ADME), and toxicity issues. Lead optimization in drug discovery, a process attempting to uncover and correct these defects of drug candidates, is highly beneficial in lowering the cost and time to develop therapeutic drugs by reducing drug candidate failures in development. At present, parallel synthesis combining with high-throughput screening has made it easier to generate highly potent compounds (i. e. , hits). However, to be a potential drug, a hit must have drug-like characteristics in addition to potency, which include optimal physicochemical properties, reasonable ph- macokinetic parameters, and good safety profiles. Therefore, research tools must be available in drug discovery to rapidly screen for compounds with favorable drug-like properties, and thus adequate resources can be directed to projects with high potential. Optimization in Drug Discovery: In Vitro Methods is a compilation of detailed experimental protocols necessary for setting up a variety of assays important in compound evaluation. A total of 25 chapters, contributed by many experts in their research areas, cover a wide spectrum of subjects including physicochemical properties, abso- tion, plasma binding, metabolism, drug interactions, and toxicity. A good pharmacokinetic profile has long been recognized as an imp- tant drug-like characteristic. Pharmacokinetic parameters are affected by many properties of drug molecules such as physicochemical nature, abso- tion, metabolic stability, and so on.

Drugs of Abuse: Neurological Reviews and Protocols is intended to provide insightful reviews of key current topics and, particularly, state-- the-art methods for examining drug actions in their various neuroanato- cal, neurochemical, neurophysiological, neuropharmacological, and molecular perspectives. The book should prove particularly useful to n- comers (graduate students and technicians) in this field, as well as to those established scientists (neuroscientists, biochemists, and molecular biologists) intending to pursue new careers or directions in the study of drugs. The book's protocols cover a wide variety of coherent methods for gathering inf- mation on quantitative changes in proteins and mRNAs at both tissue and cel- lar levels. Inducible gene expression in striatal neurons has been a hot topic over the last decade. Alterations in gene expression for a wide range of proteins in the striatum have been investigated in response to drug administration. Altered expression of given mRNAs and their product proteins constitutes essential molecular steps in the development of neuroplasticity related to long-term addictive properties of drugs of abuse. With the multiple labeling methods that are also described in the book, gene expression can be detected in a chemically identified cell phenotype; the expression of multiple genes of interest can be detected in a single cell simultaneously. Hundreds or thousands of gene expr- sion products can today be detected in one experimental setup using the pow- ful systematic cDNA macroarray or microarray screening technology. Moreover, protocols useful in analyzing the functional roles of genes and proteins (e. g.

An authoritative review of the current state-of-the-art understanding of the structure and function of the adrenergic receptor subtypes, as well as of the role played by these receptors in physiological and pathophysiological settings. Topics range from structure-function studies and the imaging of adrenergic receptors to the use of genetically altered mouse models and pharmacogenomics. Highlights include a survey of the knockout and overexpressed mouse models, a review of the new ways that adrenergic receptors can signal, and the effects of polymorphisms on clinical outcomes and on potential gene therapy applications. The side-by-side comparison of all the adrenergic receptors (a1, a2, and b) provides the reader with an excellent survey of the field, including the rationale for designing better drugs to control blood pressure and heart function.

A compendium of proven experimental approaches and strategies for studying the bioactivation, detoxification, tissue distribution, and elimination of xenobiotics in the metabolism and/or transport of various chemicals. The authors address several of the major drug metabolizing systems, including the cytochrome P450 family, flavin-containing monooxygenases, glutathione, S-transferase, glucuronidation, N-acetylation, and sulfotransferases. Additional chapters present novel approaches to the study of: signaling pathways in the regulation of drug metabolism enzymes, how the modulation of thiols and other low molecular-weight cofactors can alter drug metabolism, and how modulation of drug metabolism pathways can influence antiviral therapy.

Since Hermann Staudinger coined the concept of macromolecules as covalently linked very large molecular entities in 1922, the main focus of ongoing research has been on the synthesis of polymers and copolymers leading to a great variety of stable, structural, and functional materials. On the other hand, during the last 15 years the knowledge about supramolecular self-organization of polymers with low molecular-weight compounds by reversible non-covalent interactions gained increasing attention. In particular, the interactions of cyclic molecules, called hosts, with polymersbecame increasingly attractive, since the propertiesof polymerssuch assolubilityor crystallinitycanbe alteredwithoutthe needof chemicalreactions. In contrast to regular polymersor copolymers, supramolecularstructurescomprisedof polymers and ring-shaped hosts are not totally stable. Therefore they can show p- grammable lifetimes or adapt speci?cally to different environments. In this respect polymeric supramolecular structures resemble living systems more than regular polymers. This volume is mainly devoted to a very fascinating class of ring-shaped cyclic ?(1?4) linked oligo-glucans, named cyclodextrins. Cyclodextrins are industrially produced from the renewable resource starch. They are especially suitable for the self-assembly of water based supramolecular structures, and they are highly b- compatible. Cyclodextrinsare able to complexboth monomersand polymerswhich offer suitable hydrophobic binding sites. The driving forces are mainly van der Waals and hydrophobic interactions. This complexation process is called inc- sion and the resulting supramolecular structures inclusion compounds. In addition, Chapter 6 of this volume is devoted to another interesting host, a cyclic urea c- pound called cucurbituril, which is able to recognize cationic guest molecules in aqueous solution

This fourth edition of How Drugs Work equips readers with a set of clear concepts for matching the pharmacology to the diagnosis, and has been completely revised and updated to reflect the latest knowledge and terminology. Rather than providing overwhelmingly comprehensive information, it condenses the aspects of pharmacology directly relevant to everyday practice into a concise, accessible volume, including material on the half life of drugs, patient non-compliance and severe chronic inflammation.

Originally published in 1995, The History of Pharmacy is a critical bibliography of selected information on the history of pharmacy. The book is designed to guide students and academics through the history of science and technology. Topics range from medicine, chemical technology and the economics and business of pharmacy to pharmacy's influence in the arts. The bibliography includes an exhaustive selection of primary and secondary sources and is arranged chronologically. This book will be of interest to those researching in the area of the history of science and technology and will appeal to students and academic researchers alike.

Prepare for success on your certification exam! Mosby's Pharmacy Technician Exam Review, 4th Edition provides a complete review of core knowledge, thousands of review questions, and nine practice exams - plus a custom online engine that allows for unlimited opportunities to practice specific topics or create unique simulated exams. A bulleted, outline format makes review easier, reinforcing understanding with full-color illustrations, photographs, and summary tables. All questions reflect the latest exam blueprints. This resource provides you comprehensive support every step of the way for entry-level or sterile compounding certification. Access to this product, which may be at the discretion of your institution, is up to 3 years of online and perpetual offline access. Elsevier reserves the right to restrict or remove access due to changes in product portfolio or other market conditions. Convenient, easy-to-follow outline format provides a comprehensive review of pharmacy technician exam topics. Mapping tables link content to the knowledge categories on the PTCE and ExCPT exam blueprints, including pharmacology and medications, law, patient safety, and quality assurance. 700 electronic flashcards help you memorize key facts by covering the most commonly prescribed drugs, common herbals, abbreviations, and more. NEW! UPDATED organization of content matches the newest exam blueprints. NEW and UNIQUE! Comprehensive coverage prepares you for entry-level Pharmacy Technician certification, plus the sterile compounding specialty exam. NEW! Online custom test generator creates timed, simulated exams built from exam blueprints and allows you to focus your practice on any areas of weakness. EXPANDED! More than 2,600 review questions - all with answers and rationales - include a pretest, questions in each chapter, nine printed practice examinations, and unlimited practice and simulation online. NEW Compounded Sterile Products chapter provides an in-depth review specifically for the CSPT exam. NEW! Full-color illustrations visually reinforce important test information.

Vitamin C holds a unique place in scientific and cultural history. In this book, a group of leading scientific researchers describe new insights into the myriad ways vitamin C is employed during normal physiological functioning. In addition, the text provides an extensive overview of the following: the rationale for utilizing vitamin C in the clinic, updates on recent uses of vitamin C in cancer treatment through high-dose intravenous therapies, the role vitamin C plays in the treatment of sepsis and infectious disease, management of the ways vitamin C can improve stem cell differentiation, as well as vitamin C use in other important health situations. Features Includes chapters from a team of leading international scholars Reviews the history and recent research on the functions, benefits, and uses of vitamin C Focuses special attention on the way vitamin C can be used in the treatment of cancers Discusses how vitamin C can be employed against infectious disease

With expert contributions from experienced educators, research scientists and clinicians, Foye's Principles of Medicinal Chemistry, Eighth Edition is an invaluable resource for professional students, graduate students and pharmacy faculty alike.? This 'gold standard' text explains the chemical basis of drug action, emphasizing the structure-activity relationships, physicochemical-pharmacokinetic properties, and metabolic profiles of the most commonly used drugs. Comprehensive coverage of the most cutting edge understanding of drug chemistry, organized and written for ready comprehension Extensively referenced to allow learners to explore areas of interest in greater depth Contemporary focus on drugs viewed by practitioners as the most clinically important in today's health care environment Clinical Significance testimonials that provide a clinician's view of the relevance of medicinal chemistry to practice Science-practice interface made explicit through drug monographs that highlight therapeutic indications, adverse reactions and drug-drug interactions End-of-Chapter exercises that allow learners to test their understanding and recall of key concepts eBook available . Fast, smart, and convenient, today's eBooks can transform learning. These interactive, fully searchable tools offer 24/7 access on multiple devices, the ability to highlight and share notes, and much more

Newly focused on the practical communications skills student pharmacists need for effective practice, this updated Seventh Edition-now in full color- reflects new ACPE standards, including up-to-date coverage of the PPCP model, co-curricular experiences, interprofessional interaction and collaboration, and professional development. Practical, easy-to-use, and packed with relevant case studies and coverage of the latest advances in the field, this edition is ideal for the foundational course and pre-experiential training. Expanded emphasis on communication skill application helps students master the knowledge and skills they need for pharmacy practice Additional content added on motivational interviewing, e-commerce, contemporary ethical issues (such as medical marijuana and opioid abuse), and student-preceptor and pharmacist-management communication issues Full-color design with new diagrams and figures enhances readability Additional case studies from diverse settings prepare students to deal with the wide range of situations they will encounter in practice Stronger emphasis on assessing communication skills includes coverage of patient surveys and colleague observers Expanded coverage on choosing effective patient education materials and communicating with Limited English Proficiency (LEP) patients prepares students for professional practice Revised review questions, chapter-ending review cases, and references help students master the material eBook available for purchase. Fast, smart, and convenient, today's eBooks can transform learning. These interactive, fully searchable tools offer 24/7 access on multiple devices, the ability to highlight and share notes, and more

Making Medicines is a concise, chronological discussion of the history of therapeutics and pharmacy from the Egyptians through to the present day. It focuses on the discovery and uses of medicines to treat illness through the ages, and the evolving role of the pharmacist. Each chapter is contributed by an expert in the period or field, and illustrates how wider social, political and economic developments have influenced drug development and shaped pharmacy practice. The book has two colour-plate sections illustrating how pharmacy has developed over the centuries. Numerous photographs are also included in the text. Written by an expert in the field, this book will appeal to pharmacists and pharmacy students, as well as to other healthcare practitioners and medical historians.

Herbal Formularies for Health Professionals is a five-volume set that serves as a comprehensive, practical reference manual for herbalists, physicians, nurses, and allied health professionals. Dr. Jill Stansbury draws on her decades of clinical experience and her extensive research to provide an unparalleled range of herbal formulas. Organized by body system, each volume includes hundreds of formulas to treat common health conditions, as well as formulas that address specific energetic or symptomatic presentations. For each formula, Dr. Stansbury briefly explains how the selected herbs address the specific condition. Sidebars and user-friendly lists help readers quickly choose which herbs are best for specific presentations and detail traditional uses of both Western and traditional Asian formulas and herbs that are readily available in the United States. Volume 3 focuses on endocrine systems, offering formulas and supporting information for treating thyroid disease, adrenal disorders, diabetes, and metabolic syndrome. This volume also covers the female and male reproductive systems including conditions related to menstruation and PMS, fertility and pregnancy, and the prostate. Reproductive endocrinology is one of Dr. Stansbury's specialties, and she provides herbal formulas and therapies for pelvic inflammatory disease, genital herpes, ovarian cysts, endometriosis, PCOS, uterine fibroids, low libido, erectile dysfunction, and more. She also discusses the role of herbal medicine in prevention and treatment of reproductive cancers. Each chapter includes a materia medica section that describes individual herbs with tips on their properties, modes of action, and the specific symptoms each plant best addresses. These formularies are also a tutorial for budding herbalists on the sophisticated art of fine-tuning an herbal formula for the constitution and overall health condition of an individual patient, rather than prescribing a one-size-fits-all treatment for a basic diagnosis. The text aims to teach by example, helping clinicians develop their own intuition and ability to create effective herbal formulas. Volume 1 focuses on digestion and elimination and Volume 2 covers circulation and respiration. Volumes 4 (Neurology, Psychiatry, and Pain Management) and 5 (Immunology, Orthopedics, and Otolaryngology) will be published in 2020.

Biomaterials science has advanced dramatically in the past 50 years with the increased cooperation between engineers chemists and biologists. Whilst previously biomaterials may have been erroneously thought to encompass dressing materials or implant structures designed to replace damaged or diseased tissue, the range of clinical applications of these materials is immense. Truly "Smart" biomaterials, which have the ability to recognise, respond to and even record their environment, now exist. The presentations in this volume reflect the true inter-disciplinary nature of biomaterials science; with contributions from polymer chemists, engineers, biologists and clinicians. The presentations show the potential of these collaborations and describe how advanced biomaterials have and are being employed not only in theraputic applications, but also increasingly in diagnosis and treatment in medical science.

This book documents the long, still ongoing battle between the US Food and Drug Administration and the dietary supplement industry. It presents the complex, often subtle, and sometimes overlooked series of events that had a major impact on how dietary supplements are manufactured, marketed, sold, and used today. While the first few chapters focus on some background topics, the remaining chapters walk the reader through timeline of events, legislative actions, FDA proposed and final rules, and judicial decisions that led to our current dietary supplement regulatory framework. Interwoven in narrative are examples of the roles of science, social and public policy, politics, and popular media.

Combining two separate textbooks entitled Essentials of Human Physiology for Pharmacy and Essentials of Pathophysiology for Pharmacy into one cohesive volume, this new book seamlessly integrates material related to normal human physiology and pathophysiology into each chapter. Chapters include: Study objectives at the beginning of each chapter; Summary tables, flow charts, diagrams, and key definitions; Real life case studies to emphasize clinical application and stimulate student critical thinking; An emphasis on the rationale for drug therapy; Simple, straightforward language. Written by authors with extensive teaching experience in the areas, Essentials of Human Physiology and Pathophysiology for Pharmacy and Allied Health is a concise learning instrument that will guide students in pharmacy and allied health programs.